{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:35:57Z","timestamp":1793147757545,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41397-026-00426-0","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:43:05Z","timestamp":1788972185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers and facilitators to the implementation of pharmacogenomic testing for antidepressants use in primary care: a systematic review using the consolidated framework for implementation research"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1951-5440","authenticated-orcid":false,"given":"Muireann","family":"Counihan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Cushen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3402-5148","authenticated-orcid":false,"given":"Sookyung","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donnchadh","family":"Fitzsimons Mac Giolla Chuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Romanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Nakchbandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rose","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-8696","authenticated-orcid":false,"given":"Chad","family":"Bousman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Ledwidge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-4413","authenticated-orcid":false,"given":"Crist\u00edn","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"426_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1192\/bjp.bp.115.176479","volume":"208","author":"GS Malhi","year":"2016","unstructured":"Malhi GS, Lingford-Hughes AR, Young AH. Antidepressant treatment response: \u201cI want it all, and I want it now!\u201d. Br J Psychiatry J Ment Sci. 2016;208:101\u20133. https:\/\/doi.org\/10.1192\/bjp.bp.115.176479","journal-title":"Br J Psychiatry J Ment Sci"},{"key":"426_CR2","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2147\/CEOR.S224277","volume":"11","author":"JA Tanner","year":"2019","unstructured":"Tanner JA, Brown LC, Yu K, Li J, Dechairo BM. Canadian Medication cost savings associated with combinatorial pharmacogenomic guidance for psychiatric medications. Clin Outcomes Res CEOR. 2019;11:779\u201387. https:\/\/doi.org\/10.2147\/CEOR.S224277","journal-title":"Clin Outcomes Res CEOR"},{"key":"426_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.4088\/JCP.14m09298","volume":"76","author":"PE Greenberg","year":"2015","unstructured":"Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry. 2015;76:155\u201362. https:\/\/doi.org\/10.4088\/JCP.14m09298","journal-title":"J Clin Psychiatry"},{"key":"426_CR4","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1016\/S0140-6736(18)31948-2","volume":"392","author":"GS Malhi","year":"2018","unstructured":"Malhi GS, Mann JJ. Depression. Lancet. 2018;392:2299\u2013312. https:\/\/doi.org\/10.1016\/S0140-6736(18)31948-2","journal-title":"Lancet"},{"key":"426_CR5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41397-019-0122-0","volume":"20","author":"MA Malki","year":"2020","unstructured":"Malki MA, Pearson ER. Drug\u2013drug\u2013gene interactions and adverse drug reactions. Pharmacogenomics J. 2020;20:355\u201366. https:\/\/doi.org\/10.1038\/s41397-019-0122-0","journal-title":"Pharmacogenomics J"},{"key":"426_CR6","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1080\/03602532.2024.2385928","volume":"57","author":"LE Russell","year":"2025","unstructured":"Russell LE, Claw KG, Aagaard KM, Glass SM, Dasgupta K, Nez FL, et al. Insights into pharmacogenetics, drug-gene interactions, and drug-drug-gene interactions. Drug Metab Rev. 2025;57:272\u201390. https:\/\/doi.org\/10.1080\/03602532.2024.2385928","journal-title":"Drug Metab Rev"},{"key":"426_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4021\/jocmr2009.08.1255","volume":"1","author":"TP Aneesh","year":"2009","unstructured":"Aneesh TP, Sonal Sekhar M, Jose A, Chandran L, Zachariah SM. Pharmacogenomics: the right drug to the right person. J Clin Med Res. 2009;1:191\u20134. https:\/\/doi.org\/10.4021\/jocmr2009.08.1255","journal-title":"J Clin Med Res"},{"key":"426_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1440523","volume":"15","author":"MA Lorvellec","year":"2024","unstructured":"Lorvellec MA, Sipahimalani G, Lahutte B, Delacour H, Baldacci A, Saguin E. Pharmacogenetics testing for poor response to antidepressants: a transnosographic case series. Front Pharmacol. 2024;15:1440523 https:\/\/doi.org\/10.3389\/fphar.2024.1440523","journal-title":"Front Pharmacol"},{"key":"426_CR9","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1177\/0091270004264642","volume":"44","author":"JD Ma","year":"2004","unstructured":"Ma JD, Nafziger AN, Bertino JS. Genetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers. J Clin Pharmacol. 2004;44:447\u201356. https:\/\/doi.org\/10.1177\/0091270004264642","journal-title":"J Clin Pharmacol"},{"key":"426_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/cpt.2903","volume":"114","author":"CA Bousman","year":"2023","unstructured":"Bousman CA, Stevenson JM, Ramsey LB, Sangkuhl K, Hicks JK, Strawn JR, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A genotypes and serotonin reuptake inhibitor antidepressants. Clin Pharmacol Ther. 2023;114:51\u201368. https:\/\/doi.org\/10.1002\/cpt.2903","journal-title":"Clin Pharmacol Ther"},{"key":"426_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fphar.2011.00006","volume":"2","author":"C Crisafulli","year":"2011","unstructured":"Crisafulli C, Fabbri C, Porcelli S, Drago A, Spina E, De Ronchi D, et al. Pharmacogenetics of antidepressants. Front Pharmacol. 2011;2:6 https:\/\/doi.org\/10.3389\/fphar.2011.00006","journal-title":"Front Pharmacol"},{"key":"426_CR12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2217\/pgs-2018-0142","volume":"20","author":"CA Bousman","year":"2019","unstructured":"Bousman CA, Arandjelovic K, Mancuso SG, Eyre HA, Dunlop BW. Pharmacogenetic tests and depressive symptom remission: a meta-analysis of randomized controlled trials. Pharmacogenomics. 2019;20:37\u201347. https:\/\/doi.org\/10.2217\/pgs-2018-0142","journal-title":"Pharmacogenomics"},{"key":"426_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-1288-1061","volume":"54","author":"CA Bousman","year":"2021","unstructured":"Bousman CA, Bengesser SA, Aitchison KJ, Amare AT, Aschauer H, Baune BT, et al. Review and consensus on pharmacogenomic testing in psychiatry. Pharmacopsychiatry. 2021;54:5\u201317. https:\/\/doi.org\/10.1055\/a-1288-1061","journal-title":"Pharmacopsychiatry"},{"key":"426_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/cpt.2748","volume":"112","author":"LC Brown","year":"2022","unstructured":"Brown LC, Stanton JD, Bharthi K, Maruf AA, M\u00fcller DJ, Bousman CA. Pharmacogenomic testing and depressive symptom remission: a systematic review and meta-analysis of prospective, controlled clinical trials. Clin Pharmacol Ther. 2022;112:1303\u201317. https:\/\/doi.org\/10.1002\/cpt.2748","journal-title":"Clin Pharmacol Ther"},{"key":"426_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nurpra.2020.09.002","volume":"17","author":"L Richardson","year":"2021","unstructured":"Richardson L, Brahmbhatt A. Depression in primary care. J Nurse Pract. 2021;17:37\u201343. https:\/\/doi.org\/10.1016\/j.nurpra.2020.09.002","journal-title":"J Nurse Pract"},{"key":"426_CR16","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.3390\/jpm12111821","volume":"12","author":"E Youssef","year":"2022","unstructured":"Youssef E, Bhattacharya D, Sharma R, Wright DJ. A theory-informed systematic review of barriers and enablers to implementing multi-drug pharmacogenomic testing. J Pers Med. 2022;12:1821 https:\/\/doi.org\/10.3390\/jpm12111821","journal-title":"J Pers Med"},{"key":"426_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113336","volume":"292","author":"CATC Lunenburg","year":"2020","unstructured":"Lunenburg CATC, Gasse C. Pharmacogenetics in psychiatric care, a call for uptake of available applications. Psychiatry Res. 2020;292:113336 https:\/\/doi.org\/10.1016\/j.psychres.2020.113336","journal-title":"Psychiatry Res"},{"key":"426_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17:75 https:\/\/doi.org\/10.1186\/s13012-022-01245-0","journal-title":"Implement Sci"},{"key":"426_CR19","unstructured":"National Institute for Health Research. International prospective register of systematic reviews (PROSPERO). [cited 2025 Apr 4]. https:\/\/www.crd.york.ac.uk\/prospero\/"},{"key":"426_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1 https:\/\/doi.org\/10.1186\/2046-4053-4-1","journal-title":"Syst Rev"},{"key":"426_CR21","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71 https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"426_CR22","unstructured":"Veritas Health Innovation. Covidence Systematic Review Software. Melbourne, Australia. https:\/\/www.covidence.org."},{"key":"426_CR23","unstructured":"Critical Appraisal Skills Programme CASP Qualitative Studies Checklist. 2025 [cited 2025 Oct 13]. https:\/\/casp-uk.net\/casp-tools-checklists\/qualitative-studies-checklist\/"},{"key":"426_CR24","unstructured":"Critical Appraisal Skills Programme CASP Descriptive Study Checklist. 2025 [cited 2025 Oct 13]. https:\/\/casp-uk.net\/casp-checklists\/CASP-checklist-cross-sectional-study-2024.pdf."},{"key":"426_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-7685-1","volume":"19","author":"B Njau","year":"2019","unstructured":"Njau B, Covin C, Lisasi E, Damian D, Mushi D, Boulle A, et al. A systematic review of qualitative evidence on factors enabling and deterring uptake of HIV self-testing in Africa. BMC Public Health. 2019;19:1289 https:\/\/doi.org\/10.1186\/s12889-019-7685-1","journal-title":"BMC Public Health"},{"key":"426_CR26","doi-asserted-by":"crossref","unstructured":"Aromataris E, Lockwood C, Porritt K, Pilla B, Jordan Z, editors. JBI Manual for Evidence Synthesis. JBI; 2024 [cited 2025 Sep 8]. https:\/\/jbi-global-wiki.refined.site\/space\/MANUAL.","DOI":"10.46658\/JBIMES-24-01"},{"key":"426_CR27","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13012-021-01170-8","volume":"16","author":"PSF Chan","year":"2021","unstructured":"Chan PSF, Fang Y, Wong MCS, Huang J, Wang Z, Yeoh EK. Using consolidated framework for implementation research to investigate facilitators and barriers of implementing alcohol screening and brief intervention among primary care health professionals: a systematic review. Implement Sci. 2021;16:99 https:\/\/doi.org\/10.1186\/s13012-021-01170-8","journal-title":"Implement Sci"},{"key":"426_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13012-017-0688-3","volume":"13","author":"S Lewin","year":"2018","unstructured":"Lewin S, Booth A, Glenton C, Munthe-Kaas H, Rashidian A, Wainwright M, et al. Applying GRADE-CERQual to qualitative evidence synthesis findings: introduction to the series. Implement Sci. 2018;13:2 https:\/\/doi.org\/10.1186\/s13012-017-0688-3","journal-title":"Implement Sci"},{"key":"426_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/cl2.1230","volume":"18","author":"NR Haddaway","year":"2022","unstructured":"Haddaway NR, Page MJ, Pritchard CC, McGuinness LA. PRISMA2020: An R package and shiny app for producing PRISMA 2020\u2010compliant flow diagrams, with interactivity for optimised digital transparency and open synthesis. Campbell Syst Rev. 2022;18:e1230 https:\/\/doi.org\/10.1002\/cl2.1230","journal-title":"Campbell Syst Rev"},{"key":"426_CR30","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1176\/appi.ps.20220537","volume":"74","author":"BM Vest","year":"2023","unstructured":"Vest BM, Wray LO, Thase ME, Brady LA, Chapman SR, Oslin DW. Providers\u2019 use of pharmacogenetic testing to inform antidepressant prescribing: results of qualitative interviews. Psychiatr Serv Wash DC. 2023;74:1270\u20136. https:\/\/doi.org\/10.1176\/appi.ps.20220537","journal-title":"Psychiatr Serv Wash DC"},{"key":"426_CR31","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/07067437221140383","volume":"68","author":"C Slomp","year":"2023","unstructured":"Slomp C, Morris E, Edwards L, Hoens AM, Landry G, Riches L, et al. Pharmacogenomic testing for major depression: a qualitative study of the perceptions of people with lived experience and professional stakeholders. Can J Psychiatry Rev Can Psychiatr. 2023;68:436\u201352. https:\/\/doi.org\/10.1177\/07067437221140383","journal-title":"Can J Psychiatry Rev Can Psychiatr"},{"key":"426_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/cts.13837","volume":"17","author":"NR Sperber","year":"2024","unstructured":"Sperber NR, Roberts MC, Gonzales S, Bendz LM, Cragun D, Haga SB, et al. Pharmacogenetic testing in primary care could bolster depression treatment: a value proposition. Clin Transl Sci. 2024;17:e13837 https:\/\/doi.org\/10.1111\/cts.13837","journal-title":"Clin Transl Sci"},{"key":"426_CR33","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2217\/pgs-2020-0064","volume":"21","author":"DM Smith","year":"2020","unstructured":"Smith DM, Namvar T, Brown RP, Springfield TB, Peshkin BN, Walsh RJ, et al. Assessment of primary care practitioners\u2019 attitudes and interest in pharmacogenomic testing. Pharmacogenomics. 2020;21:1085\u201394. https:\/\/doi.org\/10.2217\/pgs-2020-0064","journal-title":"Pharmacogenomics"},{"key":"426_CR34","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3390\/jcm9030814","volume":"9","author":"CH van der Wouden","year":"2020","unstructured":"van der Wouden CH, Paasman E, Teichert M, Crone MR, Guchelaar HJ, Swen JJ. Assessing the implementation of pharmacogenomic panel-testing in primary care in the netherlands utilizing a theoretical framework. J Clin Med. 2020;9:814 https:\/\/doi.org\/10.3390\/jcm9030814","journal-title":"J Clin Med"},{"key":"426_CR35","doi-asserted-by":"publisher","first-page":"2274","DOI":"10.3390\/jcm9072274","volume":"9","author":"MJ Arwood","year":"2020","unstructured":"Arwood MJ, Dietrich EA, Duong BQ, Smith DM, Cook K, Elchynski A, et al. Design and early implementation successes and challenges of a pharmacogenetics consult clinic. J Clin Med. 2020;9:2274 https:\/\/doi.org\/10.3390\/jcm9072274","journal-title":"J Clin Med"},{"key":"426_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1274165","volume":"14","author":"J Van Heukelom","year":"2023","unstructured":"Van Heukelom J, Morgan J, Massmann A, Jacobsen K, Petry NJ, Baye JF, et al. Evolution of pharmacogenomic services and implementation of a multi-state pharmacogenomics clinic across a large rural healthcare system. Front Pharmacol. 2023;14:1274165 https:\/\/doi.org\/10.3389\/fphar.2023.1274165","journal-title":"Front Pharmacol"},{"key":"426_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-020-02919-z","volume":"20","author":"BM Vest","year":"2020","unstructured":"Vest BM, Wray LO, Brady LA, Thase ME, Beehler GP, Chapman SR, et al. Primary care and mental health providers\u2019 perceptions of implementation of pharmacogenetics testing for depression prescribing. BMC Psychiatry. 2020;20:518 https:\/\/doi.org\/10.1186\/s12888-020-02919-z","journal-title":"BMC Psychiatry"},{"key":"426_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2024.1526101","volume":"15","author":"B Roberts","year":"2024","unstructured":"Roberts B, Cooper Z, Landery G, Stanley S, Majda BT, Collins KRL, et al. Exploring perceived barriers and attitudes in young adults towards antidepressant pharmacotherapy, including the implementation of pharmacogenetic testing to optimize prescription practices. Front Pharmacol. 2024;15:1526101 https:\/\/doi.org\/10.3389\/fphar.2024.1526101","journal-title":"Front Pharmacol"},{"key":"426_CR39","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/genes14101841","volume":"14","author":"D van der Drift","year":"2023","unstructured":"van der Drift D, Simoons M, Koch BCP, Brufau G, Bindels P, Matic M, et al. Implementation of pharmacogenetics in first-line care: evaluation of its use by general practitioners. Genes. 2023;14:1841 https:\/\/doi.org\/10.3390\/genes14101841","journal-title":"Genes"},{"key":"426_CR40","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/cts.13154","volume":"15","author":"S Tuteja","year":"2022","unstructured":"Tuteja S, Salloum RG, Elchynski AL, Smith DM, Rowe E, Blake KV, et al. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. Clin Transl Sci. 2022;15:371\u201383. https:\/\/doi.org\/10.1111\/cts.13154","journal-title":"Clin Transl Sci"},{"key":"426_CR41","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.sapharm.2020.06.022","volume":"17","author":"D Bright","year":"2021","unstructured":"Bright D, Worley M, Porter BL. Patient perceptions of pharmacogenomic testing in the community pharmacy setting. Res Soc Adm Pharm RSAP. 2021;17:744\u20139. https:\/\/doi.org\/10.1016\/j.sapharm.2020.06.022","journal-title":"Res Soc Adm Pharm RSAP"},{"key":"426_CR42","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2217\/pme-2017-0036","volume":"14","author":"AA Lemke","year":"2017","unstructured":"Lemke AA, Hutten Selkirk CG, Glaser NS, Sereika AW, Wake DT, Hulick PJ, et al. Primary care physician experiences with integrated pharmacogenomic testing in a community health system. Pers Med. 2017;14:389\u2013400. https:\/\/doi.org\/10.2217\/pme-2017-0036","journal-title":"Pers Med"},{"key":"426_CR43","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13012-019-0867-5","volume":"14","author":"NM Weir","year":"2019","unstructured":"Weir NM, Newham R, Dunlop E, Bennie M. Factors influencing national implementation of innovations within community pharmacy: a systematic review applying the consolidated framework for implementation research. Implement Sci. 2019;14:21 https:\/\/doi.org\/10.1186\/s13012-019-0867-5","journal-title":"Implement Sci"},{"key":"426_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1659875","volume":"16","author":"A Coumau","year":"2025","unstructured":"Coumau A, Coumau C, Csajka C. Implementing pharmacogenetic testing in community pharmacy practice: a scoping review. Front Pharmacol. 2025;16:1659875 https:\/\/doi.org\/10.3389\/fphar.2025.1659875","journal-title":"Front Pharmacol"},{"key":"426_CR45","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/fampra\/cmac115","volume":"40","author":"E Hurley","year":"2023","unstructured":"Hurley E, Walsh E, Foley T, Heinrich CH, Byrne S, Dalton K. General practitioners\u2019 perceptions of pharmacists working in general practice: a qualitative interview study. Fam Pract. 2023;40:377\u201386. https:\/\/doi.org\/10.1093\/fampra\/cmac115","journal-title":"Fam Pract"},{"key":"426_CR46","doi-asserted-by":"publisher","first-page":"412","DOI":"10.3399\/bjgp24X739257","volume":"74","author":"N Khan","year":"2024","unstructured":"Khan N. GP workload and patient safety. Br J Gen Pract. 2024;74:412\u20133. https:\/\/doi.org\/10.3399\/bjgp24X739257","journal-title":"Br J Gen Pract"},{"key":"426_CR47","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/cpt.2079","volume":"109","author":"M Liu","year":"2021","unstructured":"Liu M, Vnencak-Jones CL, Roland BP, Gatto CL, Mathe JL, Just SL, et al. A tutorial for pharmacogenomics implementation through end-to-end clinical decision support based on ten years of experience from PREDICT. Clin Pharmacol Ther. 2021;109:101\u201315. https:\/\/doi.org\/10.1002\/cpt.2079","journal-title":"Clin Pharmacol Ther"},{"key":"426_CR48","doi-asserted-by":"publisher","first-page":"e0268534","DOI":"10.1371\/journal.pone.0268534","volume":"17","author":"K Blagec","year":"2022","unstructured":"Blagec K, Swen JJ, Koopmann R, Cheung KC, Crommentuijn-van Rhenen M, Holsappel I, et al. Pharmacogenomics decision support in the U-PGx project: results and advice from clinical implementation across seven European countries. PLoS ONE. 2022;17:e0268534 https:\/\/doi.org\/10.1371\/journal.pone.0268534","journal-title":"PLoS ONE"},{"key":"426_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1590\/1516-4446-2019-0697","volume":"42","author":"BW Dunlop","year":"2020","unstructured":"Dunlop BW. Beyond the bins: interpreting and discussing pharmacogenomic reports with psychiatric patients. Braz J Psychiatry. 2020;42:111\u20132. https:\/\/doi.org\/10.1590\/1516-4446-2019-0697","journal-title":"Braz J Psychiatry"},{"key":"426_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fgene.2020.00010","volume":"11","author":"T Rigter","year":"2020","unstructured":"Rigter T, Jansen ME, De Groot JM, Janssen SWJ, Rodenburg W, Cornel MC. Implementation of pharmacogenetics in primary care: a multi-stakeholder perspective. Front Genet. 2020;11:10 https:\/\/doi.org\/10.3389\/fgene.2020.00010","journal-title":"Front Genet"},{"key":"426_CR51","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","volume":"379","author":"DJ Kupfer","year":"2012","unstructured":"Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet. 2012;379:1045\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(11)60602-8","journal-title":"Lancet"},{"key":"426_CR52","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1176\/appi.ps.201900295","volume":"71","author":"RY Coley","year":"2020","unstructured":"Coley RY, Boggs JM, Beck A, Hartzler AL, Simon GE. Defining success in measurement-based care for depression: a comparison of common metrics. Psychiatr Serv Wash DC. 2020;71:312\u20138. https:\/\/doi.org\/10.1176\/appi.ps.201900295","journal-title":"Psychiatr Serv Wash DC"},{"key":"426_CR53","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/ajhp\/zxae110","volume":"81","author":"DL Hertz","year":"2024","unstructured":"Hertz DL, Bousman CA, McLeod HL, Monte AA, Voora D, Orlando LA, et al. Recommendations for pharmacogenetic testing in clinical practice guidelines in the US. Am J Health-Syst Pharm AJHP. 2024;81:672\u201383. https:\/\/doi.org\/10.1093\/ajhp\/zxae110","journal-title":"Am J Health-Syst Pharm AJHP"},{"key":"426_CR54","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/pharmacy9010038","volume":"9","author":"T Thornley","year":"2021","unstructured":"Thornley T, Esquivel B, Wright DJ, Dop H, Kirkdale CL, Youssef E. Implementation of a pharmacogenomic testing service through community pharmacy in the netherlands: results from an early service evaluation. Pharm Basel Switz. 2021;9:38 https:\/\/doi.org\/10.3390\/pharmacy9010038","journal-title":"Pharm Basel Switz"},{"key":"426_CR55","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.740216","volume":"12","author":"A Jameson","year":"2021","unstructured":"Jameson A, Fylan B, Bristow GC, Sagoo GS, Dalton C, Cardno A, et al. What are the barriers and enablers to the implementation of pharmacogenetic testing in mental health care settings? Front Genet. 2021;12:740216 https:\/\/doi.org\/10.3389\/fgene.2021.740216","journal-title":"Front Genet"},{"key":"426_CR56","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/jpm14101032","volume":"14","author":"A Jameson","year":"2024","unstructured":"Jameson A, Tomlinson J, Medlinskiene K, Howard D, Saeed I, Sohal J, et al. Normalising the implementation of pharmacogenomic (PGx) testing in adult mental health settings: a theory-based systematic review. J Pers Med. 2024;14:1032 https:\/\/doi.org\/10.3390\/jpm14101032","journal-title":"J Pers Med"},{"key":"426_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41436-019-0667-y","volume":"22","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Swanson KM, Rojas RL, Wang Z, St. Sauver JL, Visscher SL, et al. Systematic review of the evidence on the cost-effectiveness of pharmacogenomics-guided treatment for cardiovascular diseases. Genet Med. 2020;22:475\u201386. https:\/\/doi.org\/10.1038\/s41436-019-0667-y","journal-title":"Genet Med"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00426-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00426-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:21:56Z","timestamp":1793146916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-026-00426-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1038\/s41397-026-00426-0","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"36"}}